Arkolith/Insider Trading/KRTX/Form 4

Brannan Stephen K.

Chief Medical OfficerKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
2 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)6K$330.00$2.1M0
Mar 18, 2024Disposed to issuer(D)36K$330.00$11.9M6K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)17K$142.74$2.5M0
Mar 18, 2024Disposed to issuer(D)38K$218.03$8.2M0
Mar 18, 2024Disposed to issuer(D)13K$198.36$2.5M0
Mar 18, 2024Disposed to issuer(D)50K$230.28$11.5M0
Mar 18, 2024Disposed to issuer(D)6K$320.80$2.0M0
Mar 18, 2024Disposed to issuer(D)5K$324.55$1.5M0
Mar 18, 2024Disposed to issuer(D)10K$330.00$3.4M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-013922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML